WallStreetZenWallStreetZen

NASDAQ: SBRA
Sabra Health Care Reit Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SBRA

Based on 6 analysts offering 12 month price targets for Sabra Health Care Reit Inc

Min Forecast
$18.00+8.5%
Avg Forecast
$19.33+16.53%
Max Forecast
$20.00+20.55%

Should I buy or sell SBRA stock?

Based on 6 analysts offering ratings for Sabra Health Care Reit Inc.

Buy
Strong Buy
3 analysts 50%
Buy
1 analysts 16.67%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SBRA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SBRA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SBRA stock forecasts and price targets.

SBRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-07
lockedlocked$00.00+00.00%2024-12-05
lockedlocked$00.00+00.00%2024-10-11
lockedlocked$00.00+00.00%2024-10-01
lockedlocked$00.00+00.00%2024-09-13
Truist Securities
Top 17%
84
Strong BuyMaintains$18.00+8.50%2024-09-04Find out why

1 of 1

Forecast return on equity

Is SBRA forecast to generate an efficient return?

Company
12.67%
Industry
16.57%
Market
63.69%
SBRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SBRA forecast to generate an efficient return on assets?

Company
6.48%
Industry
7.6%
SBRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SBRA earnings per share forecast

What is SBRA's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.41+244.71%
Avg 2 year Forecast
$1.44+251.22%
Avg 3 year Forecast
$1.45+253.66%
SBRA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SBRA revenue forecast

What is SBRA's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$746.1M+9.04%
Avg 2 year Forecast
$769.2M+12.42%
Avg 3 year Forecast
$821.5M+20.06%
SBRA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SBRA earnings growth forecast

How is SBRA forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
52.53%
Industry
28.37%
Market
20.14%
SBRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SBRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SBRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SBRA revenue growth forecast

How is SBRA forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
5.91%
Industry
8.76%
Market
11.73%
SBRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SBRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SBRA vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
SBRA$16.59$19.33+16.53%Buy
AHR$27.22$29.50+8.38%Strong Buy
CTRE$26.08$31.40+20.40%Buy
NHI$66.22$83.33+25.84%Buy
MPW$3.83$5.17+34.91%Buy
View Top Healthcare Facility REIT Stocks

Sabra Health Care Reit Stock Forecast FAQ

Is Sabra Health Care Reit Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: SBRA) stock is to Buy SBRA stock.

Out of 6 analysts, 3 (50%) are recommending SBRA as a Strong Buy, 1 (16.67%) are recommending SBRA as a Buy, 2 (33.33%) are recommending SBRA as a Hold, 0 (0%) are recommending SBRA as a Sell, and 0 (0%) are recommending SBRA as a Strong Sell.

If you're new to stock investing, here's how to buy Sabra Health Care Reit stock.

What is SBRA's earnings growth forecast for 2025-2027?

(NASDAQ: SBRA) Sabra Health Care Reit's forecast annual earnings growth rate of 52.53% is forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 28.37%, and it is also forecast to beat the US market's average forecast earnings growth rate of 20.14%.

Sabra Health Care Reit's earnings in 2025 is $97,173,000.On average, 3 Wall Street analysts forecast SBRA's earnings for 2025 to be $334,368,132, with the lowest SBRA earnings forecast at $326,489,791, and the highest SBRA earnings forecast at $343,050,867. On average, 2 Wall Street analysts forecast SBRA's earnings for 2026 to be $340,684,999, with the lowest SBRA earnings forecast at $331,221,527, and the highest SBRA earnings forecast at $350,148,471.

In 2027, SBRA is forecast to generate $343,050,867 in earnings, with the lowest earnings forecast at $343,050,867 and the highest earnings forecast at $343,050,867.

What is SBRA's revenue growth forecast for 2025-2027?

(NASDAQ: SBRA) Sabra Health Care Reit's forecast annual revenue growth rate of 5.91% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 8.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.73%.

Sabra Health Care Reit's revenue in 2025 is $684,286,000.On average, 5 Wall Street analysts forecast SBRA's revenue for 2025 to be $176,520,964,013, with the lowest SBRA revenue forecast at $161,064,984,629, and the highest SBRA revenue forecast at $184,402,853,421. On average, 4 Wall Street analysts forecast SBRA's revenue for 2026 to be $181,992,980,225, with the lowest SBRA revenue forecast at $167,708,342,113, and the highest SBRA revenue forecast at $193,719,641,802.

In 2027, SBRA is forecast to generate $194,364,340,846 in revenue, with the lowest revenue forecast at $183,804,288,805 and the highest revenue forecast at $204,924,392,887.

What is SBRA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SBRA) forecast ROA is 6.48%, which is lower than the forecast US REIT - Healthcare Facilities industry average of 7.6%.

What is SBRA's Price Target?

According to 6 Wall Street analysts that have issued a 1 year SBRA price target, the average SBRA price target is $19.33, with the highest SBRA stock price forecast at $20.00 and the lowest SBRA stock price forecast at $18.00.

On average, Wall Street analysts predict that Sabra Health Care Reit's share price could reach $19.33 by Jan 7, 2026. The average Sabra Health Care Reit stock price prediction forecasts a potential upside of 16.53% from the current SBRA share price of $16.59.

What is SBRA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SBRA) Sabra Health Care Reit's current Earnings Per Share (EPS) is $0.41. On average, analysts forecast that SBRA's EPS will be $1.41 for 2025, with the lowest EPS forecast at $1.38, and the highest EPS forecast at $1.45. On average, analysts forecast that SBRA's EPS will be $1.44 for 2026, with the lowest EPS forecast at $1.40, and the highest EPS forecast at $1.48. In 2027, SBRA's EPS is forecast to hit $1.45 (min: $1.45, max: $1.45).

What is SBRA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SBRA) forecast ROE is 12.67%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.